In the current issue of Clinical Chemistry, Astion and Wilding (1) compared quadratic discriniinant function analysis (QDFA) with the new technique of neural network (NN) modeling (2) (3) (4) , for diagnosing the presence or absence of breast cancer. The authors are to be commended for presenting a lucid description of NN to this journal's readership as well as for discussing some of the limitations of their research design. Here I wish to discuss, in more detail, the further implications these limitations have for the design of future research involving NN and other multivariate techniques as approaches to clinical laboratory diagnosis. To accomplish this aim, I shall focus upon: (a) the Astion and Wilding investigation, (b) relevant findings from other investigations, and (c) some specific guidelines for further research in this important area of diagnostic inquiry.
As Astion and Wilding note, a significant shortcoming of their study is the small number of patients in the training set relative to the number of predictor variables (nine predictor variables for NNs and seven for QDFA). As the subject-to-variable ratio decreases, the probability increases that one will observe a chance relationship between a predictor variable and an output category. These chance relationships tend to make the classification rate of the training group artificially high ( 
5, 6).
Moreover, they point out a secondproblem, the small size of the cross-validation set. The small cross-validation set makes it impossible to discern whether the difference between the cross-validation rates of the NN (80%) and the discriininant function (75%) is significant. In addition, the small cross-validation group decreases the accuracy of the shrinkage estimates (i.e., the decrease in classification rate when the method is applied to a different set of subjects from the set on which it was trained).
The authors are quite correct. For example, the empirical work of Fletcher et al. (6) shows that one can expect, by chance alone, artificially high classification rates for linear discriminant function analysis (LDFA); these rates are directly dependent on the ratio of subjects to predictor variables, rather than on the number of subjects in each of the two groups. Thus, when the ratio is 1:1, whether the number of subjects in the two groups is 10,25, or 50, the expected shrinkage estimates vary within the narrow band of 34% to 36%. For a ratio of 2:1, group sizes of 20, 50, and 100 produced shrinkage estimates ranging between 21% and 23%; for a 3:1 ratio and corresponding sample sizes of 30, 75, and 150, the shrinkage estimates were all 17%; for 4:1, and group sizes of 40, 100, and 200, the shrinkage estimates were between 13% and 15%; and, finally, for ratios (7) indicates that even higher subjectto-variable ratios are needed for QDFA than for LDFA, to produce valid results, i.e., results with low shrinkage potential. Thirdly, for the NN test sample, there were nine predictor variables, producing a range of subjectto-variable ratios between 23/9 (or 2.6:1) and 34/9 (or 3.8:1). Finally, both the NN and QDFA cross-validation samples utilized all nine predictor variables with sample sizesof 10 per group, producing a subject-to-variable ratio of only 10/9 (or 1.1:1). It is important to realize that, when the test sample subject-to-variable ratios fail to produce adequate protection against shrinkage, the results are further invalidated by choosing replication samples that are characterized by even less adequate subject-to-variable ratios. Such basic design flaws call into serious doubt the putative meaning of the reported results.
Although Astion and Wilding point out that a further limitation of the study is the choice of predictor variables, they are to be commended for selecting for future research investigations variables of known diagnostic value, such as ages at menarche and at menopause.
However, Astion and Wilding provide no information about the intercorrelations of the predictor variables among themselves. Such information would shed some light on whether some of the predictor variables could feasibly be eliminated on the basis of producing redundant information.
In this general regard, Lachenbruch (8) has noted that, "if the user selects the first 10 best variables, there is a strong possibility that these best variables are noise."
Astion and Wilding conclude that: "The results strongly suggest that neural networks are a potentially useful tool for recognizing subtle diagnostic patterns in multivariate data." In fact, this may eventually prove to be the case. However, the results of their present investigation do not support this claim, nor does a recent study by Mulsant (2), which claimed a sensitivity of only 62% and an even lower positive predictive value of 57% between clinician and NN diagnosis. also examine what specific methods produce better or worse results for sensitivity, specificity, and predicted positive and negative accuracy values, as well as several other important issues (e.g., the odds that a given subject could be expected to test positive as a function of which multivariate technique was used, at a given sample size, for a given subject-to-variable ratio, at a given prevalence rate).
In summary, this brief commentary should serve as a clarion call for appropriately designed clinical and biostatistical research in the area of the multivariate interpretation of clinical laboratory data (10).
